
Job Overview
Location
Sacramento, CA
Job Type
Full-time
Category
Sales
Date Posted
April 21, 2026
Full Job Description
đź“‹ Description
- • The Prenatal Account Executive at BilliontoOne is a field sales role focused on driving adoption of the company’s groundbreaking UNITY Fetal Risk Screen — the first and only single-gene NIPT for carrier and aneuploidy screening — within OBGYN, MFM, and genetic counseling practices in the Sacramento South territory. This role is critical to expanding access to life-changing prenatal diagnostics by translating cutting-edge science into clinical impact.
- • Day to day, the Account Executive will prospect, cultivate, and manage relationships with OBGYNs, maternal-fetal medicine specialists, and genetic counselors; develop and execute strategic business plans to increase test utilization; attend industry events and conferences; lead the full sales cycle from lead generation to close; and collaborate internally to ensure accurate communication of clinical value to both customers and cross-functional teams.
- • BilliontoOne is a publicly traded Nasdaq-listed molecular diagnostics innovator headquartered in Menlo Park, with a mission to make transformative diagnostics accessible to all. Backed by over $400M in private funding and recognized as a Forbes Best Startup Employer and Great Place to Work certified, the company fosters a transparent, collaborative culture where science and compassion converge to redefine standards of care in prenatal and cancer diagnostics.
- • In this role, you will develop deep expertise in women’s health diagnostics, refine consultative sales techniques in a high-stakes healthcare environment, and contribute directly to improving patient outcomes — all while growing your career in a mission-driven, high-growth organization that values autonomy, strategic thinking, and ethical excellence.
Skills & Technologies
About BilliontoOne
BilliontoOne is a biotechnology company focused on developing advanced diagnostic tools. Their core technology leverages single-molecule analysis to detect rare biological events, such as circulating tumor DNA (ctDNA) in blood. This enables highly sensitive and early cancer detection, potentially transforming cancer screening and monitoring. The company aims to provide non-invasive methods for personalized medicine, allowing for earlier intervention and improved patient outcomes. Their platform is designed for broad applicability across various cancer types and stages, offering a significant advancement in the field of liquid biopsy and precision oncology.
Subscribe to the weekly newsletter for similar remote roles and curated hiring updates.
Newsletter
Weekly remote jobs and featured talent.
No spam. Only curated remote roles and product updates. You can unsubscribe anytime.
Similar Opportunities

Awin Group AG
8 days ago

Ontic Technologies, Inc.
11 days ago

